ArticleTrials2025

Exploring the salivary proteome following intraglandular mesenchymal stromal cell therapy for radiation-induced hyposalivation in previous head and neck cancer patients: a secondary study protocol for the MESRIX-III, randomised, controlled trial.

Amanda-Louise Fenger Carlander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.